Deep Biomarkers of Aging and Longevity – EP20: Polina Mamoshina (Deep Longevity)
In this twentieth episode, Polina Mamoshina introduces recently launched Deep Longevity, and its app (young.ai). Biomarkers of aging are introduced. She explains that they have taken a superior approach by using deep learning instead of machine learning. Aging clocks in general are covered. Finally, she shares her view that transcriptomic and proteonomic clocks are the likely future.
Lee: Hello, Polina, and welcome as guest number 20 on Quantified Health, Wellness & Aging Podcast. Polina: Hi, Lee. It’s my pleasure to be here. Lee: So, first of all, where are you? Polina: Well, I’m currently in Moscow, in Russia. So back to my hometown. Lee: Oh, I didn’t realize that. For some reason, I thought you were in... Read MoreDeep Biomarkers of Aging and Longevity – EP20: Polina Mamoshina (Deep Longevity)
Measure Glycans to Know How Much Healthy Life You’ve Already Consumed – EP17: Gordan Lauc (Genos)
In this seventeenth episode, Gordon Lauc introduces glycobiology. He details GlycanAge®, the world’s first direct-to-consumer glycan-based product. He explains that it can quantify how well interventions (e.g. supplements) work for you as an individual, and how much healthy life you’ve got left. Finally he details a potential COVID-19 glycan biomarker to accurately assess your risk.
Lee: Hello Gordan, and welcome to the 17th episode of the Quantified Health, Wellness, and Aging podcast. Gordan: Hi Lee, thank you for the invitation. Lee: Most appreciated. I was surprised that you’re over in Zagreb, which is, I would say about less than 90 minutes away from where I am. Gordan: Well, Zagreb is a nice location. It has... Read MoreMeasure Glycans to Know How Much Healthy Life You’ve Already Consumed – EP17: Gordan Lauc (Genos)
Epigenetic Health Monitoring to Reduce Your Future Illness Risk – EP13: Tom Stubbs (Chronomics)
In this thirteenth episode, Tom Stubbs, Co-Founder/CEO of Chronomics starts with introducing epigenetics. He describes the technology and expertise that he's brought together to create the only company in the world advancing the forefront of epigenetic biomarkers. He explains how their A.I. based health biomarker engine will be used to reduce your risk of future illness.
Lee: Hey, welcome Tom. Tom: Hey, Lee. Thank you for having me on the show. Pleasure to be here and looking forward to chatting with you. Lee: What’s the focus of Chronomics? Tom: We are very much focused on measuring health so people can avoid disease. Lee: Measuring health so that people can avoid disease, that sounds a little bit... Read MoreEpigenetic Health Monitoring to Reduce Your Future Illness Risk – EP13: Tom Stubbs (Chronomics)
Stop Flushing Terabytes of Data Down the Toilet – EP11: Daniel Maggs (Bisu)
In this eleventh episode, Daniel Maggs enlightens listeners as to how today we are flushing away our bodily waste daily without first capturing the highly-valuable data it contains. He details his companies forthcoming smart urine analyzer that provides personalized health advice. He shares a lot of excitement as to where home and personalized health is going.
Lee: Hello, and welcome to the show Daniel. Daniel: Thanks very much for having me Lee. Lee: I appreciate it. I can’t remember how I came across yourself. I know that I follow a partner of HAX, Benjamin Joffey who’s a friend, and I believe that bisu came through the HAX hardware accelerator program. Daniel: Yes. So Ben’s a great... Read MoreStop Flushing Terabytes of Data Down the Toilet – EP11: Daniel Maggs (Bisu)
Injectable Biosensors – EP08: Ben Hwang (Profusa)
In this eighth episode, Ben Hwang, Chairman & CEO of Profusa, provides an overview of injectable biosensors. He explains that the technology enables a model akin to getting a blood test every few seconds of our life (rather than only every few years when sick). He predicts that this “unlocked stream of biochemistry data” will become married to other data (e.g. our voice patterns) to provide a panoramic view of our health and wellbeing.
Lee: On today’s show, we have Ben Hwang, who is the Chairman and Chief Executive Officer of Profusa. From his early exposure as an undergraduate research fellow at the lab of Leroy Hood at Caltech, where the automated DNA sequencer was developed, to bringing cutting edge life science tools to the market at Life Technologies Corp, acquired by Thermo Fisher... Read MoreInjectable Biosensors – EP08: Ben Hwang (Profusa)